145 related articles for article (PubMed ID: 25827523)
1. Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors.
Boyd MJ; Bandarage UK; Bennett H; Byrn RR; Davies I; Gu W; Jacobs M; Ledeboer MW; Ledford B; Leeman JR; Perola E; Wang T; Bennani Y; Clark MP; Charifson PS
Bioorg Med Chem Lett; 2015 May; 25(9):1990-4. PubMed ID: 25827523
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
[TBL] [Abstract][Full Text] [Related]
3. N-substituted azaindoles as potent inhibitors of Cdc7 kinase.
Bryan MC; Falsey JR; Frohn M; Reichelt A; Yao G; Bartberger MD; Bailis JM; Zalameda L; Miguel TS; Doherty EM; Allen JG
Bioorg Med Chem Lett; 2013 Apr; 23(7):2056-60. PubMed ID: 23481650
[TBL] [Abstract][Full Text] [Related]
4. Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.
Tsai AW; McNeil CF; Leeman JR; Bennett HB; Nti-Addae K; Huang C; Germann UA; Byrn RA; Berlioz-Seux F; Rijnbrand R; Clark MP; Charifson PS; Jones SM
Antimicrob Agents Chemother; 2015 Oct; 59(10):6007-16. PubMed ID: 26169418
[TBL] [Abstract][Full Text] [Related]
5. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.
Byrn RA; Jones SM; Bennett HB; Bral C; Clark MP; Jacobs MD; Kwong AD; Ledeboer MW; Leeman JR; McNeil CF; Murcko MA; Nezami A; Perola E; Rijnbrand R; Saxena K; Tsai AW; Zhou Y; Charifson PS
Antimicrob Agents Chemother; 2015 Mar; 59(3):1569-82. PubMed ID: 25547360
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region.
McGowan DC; Balemans W; Embrechts W; Motte M; Keown JR; Buyck C; Corbera J; Funes M; Moreno L; Cooymans L; Tahri A; Eymard J; Stoops B; Strijbos R; Van den Berg J; Fodor E; Grimes JM; Koul A; Jonckers THM; Raboisson P; Guillemont J
J Med Chem; 2019 Nov; 62(21):9680-9690. PubMed ID: 31647875
[TBL] [Abstract][Full Text] [Related]
7. ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors.
Bandarage UK; Court J; Gao H; Nanthakumar S; Come JH; Giroux S; Green J
Bioorg Med Chem Lett; 2021 Feb; 33():127721. PubMed ID: 33259926
[TBL] [Abstract][Full Text] [Related]
8. Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity.
Desantis J; Nannetti G; Massari S; Barreca ML; Manfroni G; Cecchetti V; Palù G; Goracci L; Loregian A; Tabarrini O
Eur J Med Chem; 2017 Sep; 138():128-139. PubMed ID: 28666191
[TBL] [Abstract][Full Text] [Related]
9. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors.
Göktaş F; Özbil M; Cesur N; Vanderlinden E; Naesens L; Cesur Z
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900028. PubMed ID: 31531897
[TBL] [Abstract][Full Text] [Related]
10. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
[TBL] [Abstract][Full Text] [Related]
11. Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole.
Wang T; Duffy JP; Wang J; Halas S; Salituro FG; Pierce AC; Zuccola HJ; Black JR; Hogan JK; Jepson S; Shlyakter D; Mahajan S; Gu Y; Hoock T; Wood M; Furey BF; Frantz JD; Dauffenbach LM; Germann UA; Fan B; Namchuk M; Bennani YL; Ledeboer MW
J Med Chem; 2009 Dec; 52(24):7938-41. PubMed ID: 20014869
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
Francesconi V; Giovannini L; Santucci M; Cichero E; Costi MP; Naesens L; Giordanetto F; Tonelli M
Eur J Med Chem; 2018 Jul; 155():229-243. PubMed ID: 29886325
[TBL] [Abstract][Full Text] [Related]
13. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
[TBL] [Abstract][Full Text] [Related]
14. 6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.
Sriwilaijaroen N; Suzuki K; Takashita E; Hiramatsu H; Kanie O; Suzuki Y
J Antimicrob Chemother; 2015 Oct; 70(10):2797-809. PubMed ID: 26169554
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
[TBL] [Abstract][Full Text] [Related]
16. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
[TBL] [Abstract][Full Text] [Related]
17. Anti-influenza activity of diazaadamantanes combined with monoterpene moieties.
Suslov E; Zarubaev VV; Slita AV; Ponomarev K; Korchagina D; Ayine-Tora DM; Reynisson J; Volcho K; Salakhutdinov N
Bioorg Med Chem Lett; 2017 Oct; 27(19):4531-4535. PubMed ID: 28886889
[TBL] [Abstract][Full Text] [Related]
18. Novel influenza polymerase PB2 inhibitors for the treatment of influenza A infection.
Zhang H; Zhou L; Amichai S; Zandi K; Cox B; Schinazi R; Amblard F
Bioorg Med Chem Lett; 2019 Oct; 29(20):126639. PubMed ID: 31493987
[TBL] [Abstract][Full Text] [Related]
19. Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives.
Selvam P; Murugesh N; Chandramohan M; Sidwell RW; Wandersee MK; Smee DF
Antivir Chem Chemother; 2006; 17(5):269-74. PubMed ID: 17176631
[TBL] [Abstract][Full Text] [Related]
20. Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.
Wyatt PG; Coomber BA; Evans DN; Jack TI; Fulton HE; Wonacott AJ; Colman P; Varghese J
Bioorg Med Chem Lett; 2001 Mar; 11(5):669-73. PubMed ID: 11266166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
